PubRank

Loris De Cecco

Author PubWeight™ 29.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J Natl Cancer Inst 2005 3.26
2 Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene 2004 1.82
3 Challenges in projecting clustering results across gene expression-profiling datasets. J Natl Cancer Inst 2007 1.52
4 Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol 2009 1.43
5 MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol 2009 1.40
6 Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2011 1.14
7 Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension. Cell Cycle 2010 1.13
8 miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget 2014 1.12
9 MicroRNA detection in plasma samples: how to treat heparinized plasma. J Mol Diagn 2013 1.12
10 Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat 2010 1.02
11 Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One 2012 1.01
12 TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res 2011 1.00
13 Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands. J Cell Physiol 2012 0.93
14 FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Int J Cancer 2009 0.91
15 Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol 2014 0.88
16 Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression. Cancer Res 2014 0.88
17 Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One 2013 0.88
18 Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients. Carcinogenesis 2013 0.88
19 CTAB-urea method purifies RNA from melanin for cDNA microarray analysis. Pigment Cell Res 2004 0.86
20 Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPR. Int J Cancer 2006 0.85
21 Feasibility of circulating miRNA microarray analysis from archival plasma samples. Anal Biochem 2013 0.85
22 Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue. Int J Cancer 2012 0.85
23 Clusterin: a potential target for improving response to antiestrogens. Int J Oncol 2008 0.84
24 Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer. Endocr Relat Cancer 2008 0.81
25 Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2015 0.79
26 Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells? Oncoimmunology 2012 0.78
27 Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine. Int J Cancer 2009 0.77